New Zealand shares followed Wall Street lower as investors question whether tech and high-growth companies can deliver the earnings growth implied by their valuations. Pacific Edge led the NZX 50 Index lower, while Xero and Diligent Board Member Services paced the decline.
The NZX 50 Index fell 27.892 points, or 0.5 percent, to 5063.539. Within the index, 25 stocks fell, 17 rose and eight were unchanged. Turnover was $100.7 million.
In New York on Friday the tech-heavy Nasdaq Composite Index closed at its lowest level since February after a week of selling as investors continued to question whether sales growth by tech and bio-tech companies could deliver profits. Local tech and high-growth stocks, among the biggest gainers last year, have retreated on concern prices have run up too far and too fast.
Pacific Edge dropped 8.2 percent to a six-month low of $1.01, having fallen to 99 cents in intraday trading. The maker of a non-invasive bladder cancer test has declined 24 percent in the past month. Xero fell 6.5 percent to $29.30, the lowest in almost six months. Governance software app Diligent slipped 1.9 percent to $4.12.
"It really is selling because the rest of the technology sector around the world is coming off," said Grant Williamson, director at Hamilton Hindin Greene. "It's very difficult to put fundamental value on these types of companies because much of it is really looking into the future and trying to work out what their revenue and earnings might be."